Clinical trial
The Use of Selective Estrogen Receptor Modulators in the Treatment of…
NCT00206557 · The Alfred, Other · Completed
Key facts
| NCT number | NCT00206557 |
|---|---|
| Title | The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study |
| Official title | The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study |
| Lead sponsor | The Alfred, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder |
| Intervention type | Drug |
| Interventions | Raloxifene, Estradiol/dyhydroprogestrone |
| Enrollment | 60 |
| Start date | Oct 1, 2002 |
| Completion | Apr 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 23, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: